Keeler, a global leader in ophthalmic innovation with more than a century of heritage, and MacuMira Medical Devices Inc, a pioneering Canadian company, has announced a strategic partnership. Under the ...
MedPage Today on MSN
Mixed but Mostly Promising Results With IL-6 Inhibitor in Uveitic Macular Edema
ORLANDO -- The investigational interleukin (IL)-6 inhibitor vamikibart led to visual improvements in uveitic macular edema in ...
Times Pets on MSN
Meet Your New Therapist: A Fish
Why We’re Naturally Drawn to Water and Aquariums There is a reason people flock to beaches, lakes, and rivers when they need ...
Zacks Investment Research on MSN
REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised)
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.
News-Medical.Net on MSN
Epidural stimulation and physical rehabilitation can enhance recovery in spinal cord injury patients
Spinal cord injury (SCI) causes paralysis in roughly one million people worldwide, with incident cases rising yearly.
Promoting community understanding can make Halloween more inclusive for everyone. Some families use blue pumpkin buckets or ...
Researchers measured acetylcholine production in participants' brains at the beginning and end of the 10-week trial.
EVERSANA to provide integrated commercialization services, enhancing launch readiness and market entry for differentiated ...
The FDA approval of Epioxa is based on results from two prospective, randomized, multicenter, double-masked, Phase 3 pivotal trials that randomized a total of over 400 patients. Both trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results